PTGX fund manager activity
Protagonist Therapeutics, Inc · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q3 2019 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | New | 8,300 | $724,922 | 0.00% | Feb 17, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | No change | 159,700 | $13,948,000 | 0.33% | Feb 17, 2026 |
| Ken Fisher - Fisher Asset Management | New | 65,114 | $5,687,056 | 0.00% | Feb 9, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 21,595 | $1,886,107 | 0.01% | Feb 17, 2026 |
| Polen Capital Management | Added | 20,349 | $1,777,282 | 0.01% | Feb 12, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Stanley Druckenmiller - Duquesne Family Office | New | 159,700 | $10,609,000 | 0.27% | Nov 14, 2025 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 22,198 | $1,474,613 | 0.01% | Nov 14, 2025 |
| Polen Capital Management | Added | 20,325 | $1,350,190 | 0.00% | Nov 12, 2025 |
Newer quarters · Older quarters